Mesa Laboratories Inc reports results for the quarter ended March 31 - Earnings Summary

Mesa Laboratories

27/05/2026 13:42

Mesa Laboratories Inc MLAB.OQ reported a quarterly adjusted loss of 75 cents​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of $-1.31.  The mean expectation of three analysts for the quarter was for earnings of 34 cents per share. Wall Street expected results to range from 16 cents to 52 cents per share.
Revenue rose 2.6% to $63.72 million from a year ago; analysts expected $65.17 million. 
Mesa Laboratories Inc's reported EPS for the quarter was a loss of 75 cents​.
The company reported a quarterly loss of $4.14 million.
Mesa Laboratories Inc shares had risen by 20.1% this quarter and gained 35.2% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 10.5% in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy" 
Wall Street's median 12-month price target for Mesa Laboratories Inc is $104.50, about 1.6% below its last closing price of $106.17
This summary was machine generated from LSEG data May 27 at 12:42 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Mar. 31 2026 
0.34
-0.75
Missed
Dec. 31 2025 
0.28
0.65
Beat
Sep. 30 2025 
0.16
0.45
Beat
Jun. 30 2025 
0.44
0.85
Beat